These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8639831)
1. Characterization of vasoactive intestinal peptide receptors on human megakaryocytes and platelets. Park SK; Olson TA; Ercal N; Summers M; O'Dorisio MS Blood; 1996 Jun; 87(11):4629-35. PubMed ID: 8639831 [TBL] [Abstract][Full Text] [Related]
2. Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts. Wood CL; O'Dorisio MS J Biol Chem; 1985 Jan; 260(2):1243-7. PubMed ID: 2981838 [TBL] [Abstract][Full Text] [Related]
3. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation. Madoiwa S; Komatsu N; Mimuro J; Kimura K; Matsuda M; Sakata Y Blood; 1999 Jul; 94(2):475-82. PubMed ID: 10397715 [TBL] [Abstract][Full Text] [Related]
5. Comparative analyses of megakaryocytes derived from cord blood and bone marrow. Miyazaki R; Ogata H; Iguchi T; Sogo S; Kushida T; Ito T; Inaba M; Ikehara S; Kobayashi Y Br J Haematol; 2000 Mar; 108(3):602-9. PubMed ID: 10759720 [TBL] [Abstract][Full Text] [Related]
6. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking. McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170 [TBL] [Abstract][Full Text] [Related]
7. The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor. Couvineau A; Laburthe M Biochem J; 1985 Jan; 225(2):473-9. PubMed ID: 3977841 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Gespach C; Bawab W; de Cremoux P; Calvo F Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044 [TBL] [Abstract][Full Text] [Related]
9. The human vasoactive intestinal peptide receptor: molecular identification by covalent cross-linking in colonic epithelium. Couvineau A; Laburthe M J Clin Endocrinol Metab; 1985 Jul; 61(1):50-5. PubMed ID: 2987295 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Nagahisa H; Nagata Y; Ohnuki T; Osada M; Nagasawa T; Abe T; Todokoro K Blood; 1996 Feb; 87(4):1309-16. PubMed ID: 8608219 [TBL] [Abstract][Full Text] [Related]
11. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium. Elgavish A; Pillion DJ; Meezan E Life Sci; 1989; 44(15):1037-42. PubMed ID: 2538697 [TBL] [Abstract][Full Text] [Related]
12. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761 [TBL] [Abstract][Full Text] [Related]
13. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex. Couvineau A; Gammeltoft S; Laburthe M J Neurochem; 1986 Nov; 47(5):1469-75. PubMed ID: 3020175 [TBL] [Abstract][Full Text] [Related]
14. Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross-linking. Evidence for two classes of binding sites with different structural and functional properties. Laburthe M; Breant B; Rouyer-Fessard C Eur J Biochem; 1984 Feb; 139(1):181-7. PubMed ID: 6321173 [TBL] [Abstract][Full Text] [Related]
15. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes. Provow S; Veliçelebi G Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591 [TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor. Rameshwar P; Gascon P; Oh HS; Denny TN; Zhu G; Ganea D Exp Hematol; 2002 Sep; 30(9):1001-9. PubMed ID: 12225791 [TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor. Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842 [TBL] [Abstract][Full Text] [Related]
18. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin. Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080 [TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of thrombopoietin receptors on human megakaryocytes. Kuwaki T; Hagiwara T; Yuki C; Kodama I; Kato T; Miyazaki H FEBS Lett; 1998 May; 427(1):46-50. PubMed ID: 9613597 [TBL] [Abstract][Full Text] [Related]